Laurent Azoulay
Montreal, QC H4A3J1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 228 publications
Proton pump inhibitors use and risk of inflammatory bowel disease in children.
Journal: Gut
Published: October 22, 2025
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes.
Journal: Diabetes care
Published: October 21, 2025
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes : A Population-Based Cohort Study.
Journal: Annals of internal medicine
Published: July 14, 2025
The association between pre-existing type 2 diabetes on cancer-related and all-cause mortality among women with breast cancer.
Journal: Breast cancer research and treatment
Published: July 08, 2025
Incretin-Based Drugs and the Risk of Dementia Among Patients with Type 2 Diabetes.
Journal: Drug safety
Published: May 26, 2025
Incretin-Based Drugs and the Incidence of Endometrial Cancer Among People with Type 2 Diabetes: Active Comparator New-User Design.
Journal: Drug safety
Published: April 10, 2025
Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study.
Journal: BMJ (Clinical research ed.)
Published: February 26, 2025
Variants of physiological FDG vascular activity on digital PET.
Journal: Nuclear medicine communications
Published: November 28, 2024
Metformin to treat breast cancer: an application of the prevalent new-user design for observational studies with no active comparator.
Journal: Journal of clinical epidemiology
Published: October 16, 2024
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes.
Journal: Diabetes care
Published: September 05, 2024
Last Updated: 09/26/2026